2024-11-182024-11-182019-08-181052-0295https://doi.org/10.1080/10520295.2019.1580387https://hdl.handle.net/11452/48019We investigated the effect of tamoxifen (TAM) treatment on the Notch signaling pathway in mouse ovary. Mice were randomly divided into four groups. Control group A animals were untreated. Control group B animals were treated with the vehicle only. Animals of the 0.5 TAM group received 0.5 mg/day TAM. Animals of the 1.5 TAM group received 1.5 mg/day of TAM. TAM was injected subcutaneously for 5 days. Body weights were measured at the start and end of the experiment. Sections were stained using Crossman's modified trichrome to examine general ovarian structure. Other sections were immunostained to demonstrate Jagged 1, Ki 67 and Notch 2. The TUNEL method was used to detect apoptosis. No significant differences in body weight or ovarian weight were found among the experimental groups. The number of primordial follicles was greater in the treatment groups than in the control groups, while the number of antral follicles and corpora lutea were reduced in the treatment groups. Cell proliferation rates were decreased by TAM treatment and cystic follicles were formed in the ovarian stroma. Notch 2 expression in the granulosa cells was increased following TAM administration, but no change was found in Jagged 1 expression. TAM administration suppressed follicular development and exhibited a negative effect on ovarian morphology. Our findings suggest that the Notch pathway participates in the action of TAM. We suggest that it may be useful to use Notch pathway regulators to adjust the effects of TAM on the ovary.eninfo:eu-repo/semantics/closedAccessBreast-cancer patientsPostmenopausal patientsEstrogen-receptorDose tamoxifenFertilityMouseDifferentiationProliferationToremifeneAntiestrogensApoptosisFolliculogenesisJagged 1Notch 2OvaryTamoxifenScience & technologyLife sciences & biomedicineCell biologyBiotechnology & applied microbiologyArticle00048361870000441041994610.1080/10520295.2019.1580387